Navigation Links
John McEnroe is Serious About Getting Men to Take the '50 Over 50 Prostate Health Challenge'

PHILADELPHIA, March 16 /PRNewswire/ -- Three-time Wimbledon and four-time US Open Champion John McEnroe has teamed up with GlaxoSmithKline (NYSE: GSK) to create a public-education initiative entitled the "50 Over 50 Prostate Health Challenge."

Fifty percent of men over 50 years of age have an enlarging prostate; if left untreated it can lead to worsening urinary symptoms and even prostate-related surgery.

"I just celebrated my 50th birthday, and while I'm still as active as ever, I know there are certain health issues I need to stay on top of, including my prostate health," said McEnroe. "Now I'm asking other men to take the '50 Over 50 Prostate Health Challenge.' It's all about talking to your doctor and getting serious about your prostate health."

As a part of the campaign, an interactive web site,, has been created where men can start the "Prostate Health Challenge." The challenge is to take three easy steps to get serious about prostate health: a brief online prostate health assessment; seeing a doctor for a prostate-health exam; and knowing your PSA (Prostate-specific antigen) level. PSA level, obtained from a simple blood test, is a protein marker that can rise when a prostate condition is present.

McEnroe will also be featured in public education video messages that will appear throughout the year on network television, internet sites and at The first video vignette will air on April 4 in between the first and second games of the men's college basketball semi final on CBS. There will also be national print messages in March and April running in such publications as USA Today, Sports Illustrated, Time and Newsweek.

"Prostate health can be awkward to talk about, so we've created a series of hopefully memorable, vignettes to help get men talking. I am hoping my involvement will be motivational and encourage men to take the Challenge and take control of their prostate health," added McEnroe.

About Enlarging Prostate

Enlarging prostate is a prevalent and progressive condition that affects approximately 50 percent of men over 50 years of age and over 90 percent of men older than age 80. An enlarged prostate can cause changes in urinary habits because of its location around the urethra. Over time, the prostate can continue to grow and urinary symptoms may worsen as the bladder loses the ability to empty itself. Left untreated, in severe cases, an enlarged prostate can lead to serious long-term problems including acute urinary retention (AUR) and the need for prostate-related surgery.

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Superstar John McEnroe to Highlight The Kennedy Funding Invitational Tennis Tournament, July 9-13, 2008
2. Local Communities Get Serious About Saving Lives Through Project Lifesaver Tracking Equipment, Says NAA
3. New Texas Study Reveals Serious Flaws in Abstinence Programs
4. Harmonix Music Systems, Inc. and MTV Games Make a Donation to Starlight and Bring Rock Band(R) to Thousands of Seriously Ill Children
5. IMPACT Study Demonstrates That Longer Prophylactic Therapy With Valcyte(R) (Valganciclovir Hydrochloride Tablets) Increases Protection Against CMV - the Most Serious Viral Infection Affecting Transplant Patients
6. Sexual health promotion is low among people with serious mental illnesses, despite higher risk
7. Pharmaceuticals sold in Sweden cause serious environmental harm in India
8. Physical activity, mood and serious mental illness
9. AFB Survey Finds Drug Labeling Puts People with Vision Loss at Serious Medical Risk
10. Late preterm births present serious risks to newborns
11. Americans Want Schools to Take Recess Seriously
Post Your Comments:
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., the first ... annual Employee Benefits Conference. The Employee Benefits Conference was hosted by the International ... November 11th, 2015. The conference was held at the Hawaii Convention Center in ...
(Date:11/25/2015)... IN (PRWEB) , ... November 25, 2015 , ... ... water accessible for all, Water For Empowerment ™ attracts volunteers together who ... clean water by empowering women as key stakeholders in the process. The non-profit ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical ... more about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared ... thicker and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... ... 25, 2015 , ... Lakeview Health, a Jacksonville-based drug and ... sobriety and show through pictures what a positive difference it makes. The social ... the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short stories ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015  The total global healthcare industry is expected to ... Latin America has the highest projected growth ... Japan ), is second with growth projected at ... increased healthcare expenditure. In 2013-2014, total government funded healthcare was ... 2008-2009 to 41.2% in 2013-2014. In real terms, out of ...
(Date:11/25/2015)... 25, 2015 AAIPharma Services Corp./Cambridge Major ... at least $15.8  Million to expand its laboratories ... . The expansion will provide additional office ... growing demands of the pharmaceutical and biotechnology markets. ... will provide up to 40,000 square feet of ...
(Date:11/25/2015)... Kitov Pharma ceuticals ... biopharmaceutical company focused on the development of therapeutic candidates ... announced the closing of its previously announced underwritten public ... each representing 20 ordinary shares of the Company, and ... and warrants were issued in a fixed combination of ...
Breaking Medicine Technology: